Abstract:Expression of programmed death ligand 1 (PD-L1) is rendered a possible biomarker for immunotherapy targeting programmed death protein 1 (PD1) and PD-L1. Durable clinical responses have been demonstrated in patients with squamous cell carcinoma (SqCC) of the lung. Tumor infiltrating lymphocytes (TILs) are also regarded important players in immunomodulating therapies. Still, there is much uncertainty regarding the expression of the markers and associated tumor characteristics. We aimed to assess the prognostic impact and heterogeneity of PD-L1 expression across two antibodies, in conjunction with TILs, in SqCC of the lung. PD-L1 expression was investigated on a tissue microarray (TMA) of pulmonary SqCC using immunohistochemistry and two different clones (SP142, E1L3N). The cohort comprised all consecutive patients with primary resected pulmonary SqCC, without previous SqCC of other sites, diagnosed 2000-2013 at the Institute of Pathology, University of Bern. Epithelial expression of PD-L1 in primary tumors (n=372) and mediastinal lymph node (LN) metastases (n=27) was evaluated across 8 TMA cores per tumor using the following increment intervals: 0%; 1%; 5%; 10%; 20%; 30%, 50%. Intratumoral and intraepithelial infitrates of CD8+ T lymphocytes were determined. Results were compared with clinic-pathologic parameters including tumor related survival. The staining results correlated significantly between the two antibodies (r=0.822; p<0.001) with the best congruence for tumors with ≤1% or ≥30% positivity. These tumors had also very homogenous staining results across all TMA cores, indicating low levels of intratumoral heterogeneity, in contrast to tumors with 1-30% PD-L1 positivity (p<0.001 both antibodies). Stainings correlated significantly between primary tumors and LN metastases (p<0.001 both antibodies). High PD-L1 expression correlated with intratumoral and intraepithelial CD8+ lymphocyte counts in primaries (p<0.001 both antibodies). PD-L1 expression was not significantly associated with pT or pN staging. High PD-L1 expression was associated with shorter tumor related survival. Cut-offs with the best prognostic discrimination were 30% positivity for SP142 and 50% for E1LN3 in univariate analysis (p=0.001/p=0.008). PD-L1 expression, pT category and age of the patients, but not CD8+ TILs were independent prognostic factors in multivariate analysis (HR=2.265, p=0.013 for SP142; HR=2.323, p=0.014 for E1LN3). PD-L1 expression was an independent predictor of shorter tumor related survival in pulmonary SqCC across all stages. The homogeneity of PD-L1 expression in "no" or "high" staining tumors across different cores and primary versus LN metastases indicates a valid assessment on small tissue samples and LN-metastases.

PIWI-Like 1 and PIWI-Like 2 Expression in Breast Cancer

The expression of PIWI protein in tissue of human colon cancer and its clinical significance

The Expression of Stem Cell Protein Piwil2 and Pir-932 in Breast Cancer.

Piwil2 Is Expressed In Various Stages Of Breast Cancers And Has The Potential To Be Used As A Novel Biomarker

Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survival

Expression of PIWIL2 in Oral Cancer and Leukoplakia: Prognostic Implications and Insights from Tumors.

Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancer

Overexpression of Phosphoprotein Phosphatase 2A Predicts Worse Prognosis in Patients with Breast Cancer: a 15-Year Follow-Up

Overexpression of PIWI Proteins in Human Stage III Epithelial Ovarian Cancer with Lymph Node Metastasis.

The PIWI Protein Acts As a Predictive Marker for Human Gastric Cancer.

High Expression of PIWIL2 Promotes Tumor Cell Proliferation, Migration and Predicts a Poor Prognosis in Glioma.

Low Expression of PALB2 is Associated with Poor Survival in Chinese Women with Primary Breast Cancer.

PIWI Proteins and PIWI-Interacting RNA: Emerging Roles in Cancer.

Prognostic Role of p53 Immunohistochemical Status in Invasive Breast Cancer. A Retrospective Review of 1387 Cases With Luminal-Like/Her2 Negative Breast Tumors

Role of programmed cell death ligand-1 expression on prognostic and overall survival of breast cancer: A systematic review and meta-analysis.

Identification of Piwil2-Like (pl2l) Proteins That Promote Tumorigenesis

HER2-Low Breast Cancer: Molecular Characteristics and Prognosis

Pan-cancer Analysis on the Role of PIK3R1 and PIK3R2 in Human Tumors

Piwi-Interacting Rnas: A New Class Of Regulator In Human Breast Cancer

P2.01-052 High PD-L1 Expression is Associated with Worse Prognosis in Primary Resected Squamous Cell Carcinomas of the Lung

Prognostic and clinicopathological value of PD-L1 expression in primary breast cancer: a meta-analysis